Cogent Biosciences (COGT) Long-Term Deferred Tax (2017 - 2018)
Cogent Biosciences' (COGT) quarterly Long-Term Deferred Tax came in at $2.6 million in Q1 2018, up 90.24% on a QoQ basis from $1.4 million in Q4 2017.
Cogent Biosciences (COGT) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends
Cogent Biosciences (COGT) has 2 years of Long-Term Deferred Tax data on file, last reported at $2.6 million in Q1 2018.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $2.6 million in Q1 2018; TTM through Mar 2018 was $2.6 million, a N/A change from a year earlier, with the FY2017 full-year figure at $1.4 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q1 2018 stood at $2.6 million, up from $1.4 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for COGT reached as high as $2.6 million in Q1 2018 and fell as low as $1.4 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 2.61 Mn |
| Dec 31, 2017 | 1.37 Mn |